$CHHE
China Health Industries Holdings, Inc. Stock $chhe

$chhe Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023037911 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$57.51K	$21.42K	$0.00
YoY Change	21200.0%		-100.0%
Cost Of Revenue	$62.63K	$19.08K	$10.00
YoY Change	3478.86%	190730.0%	-100.0%
Gross Profit	-$5.120K	$2.333K	-$10.00
YoY Change	245.95%	-23430.0%	-100.0%
Gross Profit Margin	-8.9%	10.89%
Selling, General & Admin	$574.4K	$152.6K	$136.4K
YoY Change	-38.57%	11.9%	-17.95%
% of Gross Profit		6542.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$159.3K	$179.2K	$264.5K
YoY Change	-22.73%	-32.26%	-21.72%
% of Gross Profit		7679.85%
Operating Expenses	$604.5K	$331.8K	$315.9K
YoY Change	-63.29%	5.03%	-1.85%
Operating Profit	-$609.6K	-$329.5K	-$315.9K
YoY Change	-63.01%	4.28%	-292.05%
Interest Expense	$26.24K
YoY Change	-83.38%
% of Operating Profit
Other Income/Expense, Net	-$8.000K	$39.18K	-$60.00
YoY Change	-100.7%	-65395.0%	-60.0%
Pretax Income	-$591.3K	-$290.3K	-$278.9K
YoY Change	68.46%	4.08%	-239.43%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$591.3K	-$290.3K	-$278.9K
YoY Change	67.07%	4.08%	-373.37%
Net Earnings / Revenue	-1028.24%	-1355.47%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	-$0.01	$0.00	-$4.256K
COMMON SHARES
Basic Shares Outstanding	65.54M shares	65.54M shares	65.54M shares
Diluted Shares Outstanding		65.54M shares	65.54M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.25K	$43.34M	$47.41M
YoY Change	-99.89%	-8.59%	15.31%
Cash & Equivalents	$47.25K	$43.34M	$47.41M
Short-Term Investments
Other Short-Term Assets	$40.88M	$225.6K	$259.4K
YoY Change	16591.38%	-13.0%	12.02%
Inventory	$40.61K	$399.2K	$861.5K
Prepaid Expenses		$17.92K
Receivables		$9.331K	$16.94K
Other Receivables	$1.921K	$28.93K	$33.46K
Total Short-Term Assets	$40.97M	$44.00M	$48.58M
YoY Change	-10.15%	-9.43%	2.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.727M	$2.905M	$4.031M
YoY Change	-13.64%	-27.94%	-4.31%
Goodwill
YoY Change
Intangibles	$964.8K	$1.027M
YoY Change	-31.7%
Long-Term Investments
YoY Change
Other Assets		$0.00	$2.990K
YoY Change		-100.0%	-52.24%
Total Long-Term Assets	$4.112M	$4.505M	$5.653M
YoY Change	-20.16%	-20.32%	-9.93%
TOTAL ASSETS
Total Short-Term Assets	$40.97M	$44.00M	$48.58M
Total Long-Term Assets	$4.112M	$4.505M	$5.653M
Total Assets	$45.08M	$48.50M	$54.23M
YoY Change	-11.16%	-10.56%	1.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$286.9K	$305.0K	$347.0K
YoY Change	-14.35%	-12.11%	-13.04%
Accrued Expenses	$90.99K	$111.4K	$169.7K
YoY Change	-43.98%	-34.36%	-35.84%
Deferred Revenue
YoY Change
Short-Term Debt	$5.154M	$5.770M	$7.457M
YoY Change	-23.75%	-22.62%	-5.93%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.973M	$6.586M	$9.504M
YoY Change	-24.82%	-30.71%	4.57%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.973M	$6.586M	$9.504M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$5.973M	$6.586M	$9.504M
YoY Change	-24.82%	-30.71%	4.57%
SHAREHOLDERS EQUITY
Retained Earnings	$41.29M	$41.88M
YoY Change	-0.98%
Common Stock	$528.5K	$6.554K
YoY Change	7964.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.11M	$41.92M	$44.73M
YoY Change
Total Liabilities & Shareholders Equity	$45.08M	$48.50M	$54.23M
YoY Change	-11.16%	-10.56%	1.39%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$591.3K	-$290.3K	-$278.9K
YoY Change	67.07%	4.08%	-373.37%
Depreciation, Depletion And Amortization	$159.3K	$179.2K	$264.5K
YoY Change	-22.73%	-32.26%	-21.72%
Cash From Operating Activities	-$42.76M	-$22.40K	$172.7K
YoY Change	4894.6%	-112.97%	-76.73%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-42.76M	-22.40K	172.7K
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	0.000	0.000	0.000
Net Change In Cash	-42.76M	-22.40K	172.7K
YoY Change	4894.6%	-112.97%	-76.66%
FREE CASH FLOW
Cash From Operating Activities	-$42.76M	-$22.40K	$172.7K
Capital Expenditures		$0.00	$0.00
Free Cash Flow		-$22.40K	$172.7K
YoY Change		-112.97%	-76.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Interest Expense InterestExpense		usd
CY2022Q1	us-gaap	Interest Expense InterestExpense		usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
	chhe	Payments To Expenditure In Construction In Progress PaymentsToExpenditureInConstructionInProgress		usd
	chhe	Payments To Expenditure In Construction In Progress PaymentsToExpenditureInConstructionInProgress		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-51060
	dei	Entity Registrant Name EntityRegistrantName	CHINA HEALTH INDUSTRIES HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-0827216
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3199-1 Longxiang Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Songbei District
	dei	Entity Address City Or Town EntityAddressCityOrTown	Harbin City
	dei	Entity Address Country EntityAddressCountry	CN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	150028
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	65539737	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43336642	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q1	chhe	Advances To Suppliers AdvancesToSuppliers	207717	usd
CY2022Q2	chhe	Advances To Suppliers AdvancesToSuppliers	214915	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17922	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	30004	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	43999698	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	45597492	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2904725	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3158021	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1026537	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1412603	usd
CY2023Q1	chhe	Construction In Progress ConstructionInProgress	573416	usd
CY2022Q2	chhe	Construction In Progress ConstructionInProgress	579402	usd
CY2023Q1	us-gaap	Assets Assets	48504376	usd
CY2022Q2	us-gaap	Assets Assets	50747518	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	304961	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44789999	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9331	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9567	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	399160	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	521229	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	28926	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	31778	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	334972	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	83414	usd
CY2022Q2	us-gaap	Other Liabilities OtherLiabilities	82323	usd
CY2023Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	169891	usd
CY2022Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	472307	usd
CY2023Q1	us-gaap	Debt Current DebtCurrent	5770209	usd
CY2022Q2	us-gaap	Debt Current DebtCurrent	6759761	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	111403	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	162431	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	145717	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	133005	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6585595	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7944799	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65539737	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65539737	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65539737	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65539737	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	6554	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	6554	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	521987	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	521987	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-527688	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	538820	usd
CY2023Q1	chhe	Statutory Reserves StatutoryReserves	38679	usd
CY2022Q2	chhe	Statutory Reserves StatutoryReserves	38679	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41879249	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41696679	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	41918781	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42802719	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48504376	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50747518	usd
CY2023Q1	us-gaap	Revenues Revenues	21416	usd
CY2022Q1	us-gaap	Revenues Revenues	1	usd
	us-gaap	Revenues Revenues	54066	usd
	us-gaap	Revenues Revenues	269	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	19083	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	7	usd
	us-gaap	Cost Of Revenue CostOfRevenue	48728	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1762	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	2333	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-6	usd
	us-gaap	Gross Profit GrossProfit	5338	usd
	us-gaap	Gross Profit GrossProfit	-1493	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	152627	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	136397	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	710946	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	484056	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	179171	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	179525	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	527413	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	539487	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	331798	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	315922	usd
	us-gaap	Operating Expenses OperatingExpenses	1238359	usd
	us-gaap	Operating Expenses OperatingExpenses	1023543	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-329465	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-315928	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1233021	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1025036	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	26847	usd
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	37063	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	87376	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	118695	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12426	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	142	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1328680	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33024	usd
CY2023Q1	chhe	Bank Charges BankCharges	96	usd
CY2022Q1	chhe	Bank Charges BankCharges	199	usd
	chhe	Bank Charges BankCharges	465	usd
	chhe	Bank Charges BankCharges	516	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	39177	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	37006	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1415591	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	151203	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-290288	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-278922	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	182570	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-873833	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-290288	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-278922	usd
	us-gaap	Net Income Loss NetIncomeLoss	182570	usd
	us-gaap	Net Income Loss NetIncomeLoss	-873833	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-177887	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-237473	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	1066508	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-828878	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-112401	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41449	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-883938	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44955	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0044
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0043
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.0028
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0133
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65539737	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65539737	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65539737	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65539737	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44774641	usd
	us-gaap	Net Income Loss NetIncomeLoss	-873833	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	828878	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	44729686	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42802719	usd
	us-gaap	Net Income Loss NetIncomeLoss	182570	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1066508	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	41918781	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44771135	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-278922	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	237473	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	44729686	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42031182	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-290288	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	177887	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	41918781	usd
	us-gaap	Profit Loss ProfitLoss	182570	usd
	us-gaap	Profit Loss ProfitLoss	-873833	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	527413	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	624443	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-10659	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2282640	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-2117	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	6	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-108165	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	82142	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-13109	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11573	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-17633	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-64442	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-242894	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1112417	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-41682	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	54746	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-46571	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-50673	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	5202	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-9016	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	489796	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2971902	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1943153	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	90374	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1453357	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3062276	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44789999	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44346744	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43336642	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47409020	usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	chhe	Loan From Related Party For The Construction Of A Facility LoanFromRelatedPartyForTheConstructionOfAFacility		usd
	chhe	Loan From Related Party For The Construction Of A Facility LoanFromRelatedPartyForTheConstructionOfAFacility		usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates and Assumptions</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires Management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. Significant estimates and assumptions by Management include, among others, useful life of long-lived assets and intangible assets, valuation of inventory, accounts receivable and notes receivable, impairment analysis of long-lived assets, construction in progress, intangible assets, and deferred taxes. While Management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	43336642	usd
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	44789999	usd
CY2023Q1	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings		usd
CY2022Q2	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings		usd
CY2023Q1	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	56896	usd
CY2022Q2	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	58336	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	47565	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	48769	usd
CY2023Q1	chhe	Advances To Suppliers AdvancesToSuppliers	207717	usd
CY2022Q2	chhe	Advances To Suppliers AdvancesToSuppliers	214915	usd
	chhe	Percentage Of Enterprises Tax Rate PercentageOfEnterprisesTaxRate	0.25	pure
CY2023Q1	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings		usd
CY2022Q2	us-gaap	Inventory Net Of Allowances Customer Advances And Progress Billings InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings		usd
	chhe	Depreciation Expense Charged To Cost Of Goods Sold DepreciationExpenseChargedToCostOfGoodsSold		usd
	chhe	Depreciation Expense Charged To Cost Of Goods Sold DepreciationExpenseChargedToCostOfGoodsSold		usd
	chhe	Income Tax Services Rate Percentage IncomeTaxServicesRatePercentage	0.16	pure
	chhe	Value Added Tax Payables ValueAddedTaxPayables	30534	usd
CY2022	chhe	Value Added Tax Payables ValueAddedTaxPayables	29835	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentrations of Business and Credit Risks</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the Company’s manufacturing is located in the PRC. There can be no assurance that the Company will be able to successfully continue to manufacture its products and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Moreover, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. These contingencies include general economic conditions, prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company is dependent on trade in the PRC, the Company is subject to various additional political, economic and other uncertainties. Among other risks, the Company’s operations will be subject to the risks of restrictions on transfer of funds, domestic customs, changing taxation policies, foreign exchange restrictions, and political and governmental regulations. The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between USD and the Chinese currency RMB. The results of operations denominated in foreign currency are translated at the average rate of exchange during the reporting periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	119990	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	213055	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	87430	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	90303	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	3136	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	82412	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	188604	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	135459	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	399160	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	521229	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	573416	usd
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	579402	usd
CY2012Q2	chhe	Estimated Total Cost Of Construction EstimatedTotalCostOfConstruction	1860000	usd
CY2012Q2	chhe	Estimated Total Cost Of Construction EstimatedTotalCostOfConstruction	12800000	cny
CY2023Q1	chhe	Construction In Progress Percentage ConstructionInProgressPercentage	0.7136	pure
CY2023Q1	chhe	Cost Of Construction In Progress costOfConstructionInProgress	1329984	usd
CY2023Q1	chhe	Cost Of Construction In Progress costOfConstructionInProgress	9133796	cny
CY2023Q1	chhe	Construction In Progress Amount ConstructionInProgressAmount	764882	usd
CY2023Q1	chhe	Construction In Progress Amount ConstructionInProgressAmount	5252904	cny
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3827381	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3879752	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2904725	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3158021	usd
	us-gaap	Depreciation Depreciation	179555	usd
	us-gaap	Depreciation Depreciation	260224	usd
	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	179555	usd
	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	260224	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-5276573	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-5050012	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1026537	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1412603	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P10Y
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	347858	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	364219	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	5770209	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	6759761	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1029615	usd
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1096936	usd
CY2023Q1	chhe	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	-11891	usd
CY2022Q2	chhe	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	-12192	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1017724	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1084744	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-290288	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-278922	usd
	us-gaap	Net Income Loss NetIncomeLoss	182570	usd
	us-gaap	Net Income Loss NetIncomeLoss	-873833	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0044
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0043
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.0028
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0133
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65539737	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65539737	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65539737	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65539737	shares
	chhe	Number Of Suppliers NumberOfSuppliers	1	pure
	chhe	Number Of Customers NumberOfCustomers	1	pure
	dei	City Area Code CityAreaCode	86-451
CY2023Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2023Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.0028
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.0043
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.0044
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.0133
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65539737	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65539737	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65539737	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65539737	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001309057

Files In Submission

Name	View Source	Status
0001213900-23-037911-index-headers.html	Edgar Link	pending
0001213900-23-037911-index.html	Edgar Link	pending
0001213900-23-037911.txt	Edgar Link	pending
0001213900-23-037911-xbrl.zip	Edgar Link	pending
chhe-20230331.xsd	Edgar Link	pending
f10q0323ex31-1_chinahealth.htm	Edgar Link	pending
f10q0323ex31-2_chinahealth.htm	Edgar Link	pending
f10q0323ex32-1_chinahealth.htm	Edgar Link	pending
f10q0323_chinahealth.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
chhe-20230331_cal.xml	Edgar Link	unprocessable
chhe-20230331_def.xml	Edgar Link	unprocessable
chhe-20230331_lab.xml	Edgar Link	unprocessable
chhe-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_chinahealth_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHHE
China Health Industries Holdings, Inc. Stock $chhe

2023 Q2 Form 10-Q Financial Statement

#000121390023037911 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHHE China Health Industries Holdings, Inc. Stock $chhe

2023 Q2 Form 10-Q Financial Statement

#000121390023037911 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHHE
China Health Industries Holdings, Inc. Stock $chhe